Viemed Healthcare, Inc. · NASDAQ:VMD
Viemed Healthcare — Q1 2025 Earnings Presentation
11 slides from Viemed Healthcare's earnings presentation, May 7, 2025
Slide 1: Financial Supplement First Quarter 2025
Financial Supplement NASDAQ: VMD Leading th e Healthcare Industry in Home Respiratory Care May 7, 2025 1 First Quarter 2025
Slide 2: Disclaimers: Forward Looking Statements
Disclaimers Forward Looking Statements Certain statements contained in this Financial Supplement may constitute “forward-looking statements” within the meaning of the U.S. Private Securities Litigation Reform Act of 1995 or “forward-looking information” as such term is defined in applicable Canadian
Slide 3: Key Themes for Q1 2025
Key Themes for Q1 2025 3 We saw marked improvement in each of the businesses in what is historically our toughest quarter. Benefits from the sales restructuring implemented in 2024 were evident in the non-invasive ventilation business while the staffing business continued its strong growth pace. Sle
Slide 4: Financial and Operational Highlights
Financial and Operational Highlights 4 (expressed in thousands of U.S. Dollars, except operational information). (1) Refer to "Non-GAAP Reconciliations" in this presentation for definition of Adjusted EBITDA and a reconciliation to its most comparable GAAP measure. (2) Vent Patients represents the n
Slide 5: Service, Payor and Revenue Mix
Medicare 41% Medicaid/ MCO 8% Medicare Advantage 21% Commercial 17% Other 13% Ventilation 54% Sleep 16% Oxygen 10% Other 20% Q1 2025 Rental 76% Sales 24% Medicare 43% Medicaid/ MCO 7% Medicare Advantage 20% Commercial 17% Other 13% Ventilation 58% Sleep 14% Oxygen 11% Other 17% Q1 2024 Service, Payo
Slide 6: Revenue Highlights
Revenue Highlights 6 For the quarter ended 3/31/25 12/31/24 9/30/24 6/30/24 3/31/24 12/31/23 9/30/23 6/30/23 Rental Revenue (expressed in thousands of USD): Ventilators, non-invasive & invasive $32,159 $33,173 $31,772 $30,445 $29,187 $29,077 $28,322 $25,712 Other home medical equipment rentals $12,9
Slide 7: Net CAPEX
Net CAPEX 7 For the quarter ended 3/31/25 12/31/24 9/30/24 6/30/24 3/31/24 12/31/23 9/30/23 6/30/23 Purchase of property and equipment 15,483 11,829 11,002 8,934 6,006 7,932 7,402 6,078 Proceeds from sale of property and equipment (6,953) (2,881) (6,033) (766) (641) (460) (353) (999) Net CAPEX 8,530
Slide 8: Liquidity Metrics
Liquidity Metrics 8 Positioned for growth • The Company maintains a healthy balance sheet with no net debt as of March 31, 2025, providing significant financial flexibility. • As of March 31, 2025, the Company has $55 million in unfunded commitments available under its existing credit facilities, su
Slide 9: 2025 Guidance – Commentary
2025 Guidance – Commentary 9 • Strength in operational metrics in Q1, which should translate to better financial performance during the year, provides confidence in raising the lower end of guidance for both revenue and Adjusted EBITDA • Guidance increase reflects continued strength in operational p
Slide 10: 2025 Guidance – Commentary: Core Metrics
2025 Guidance – Commentary 10 Core Metrics • Net revenue of $256 million to $265 million; an increase from $254 million to $265 million • Adjusted EBITDA of $55 million to $58 million (21%-23% of net revenue); an increase from $54 million to $58 million Directional Commentary on Quarterly Cadence •
Slide 11: Non-GAAP Reconciliations
Non-GAAP Reconciliations 11 (a) Represents non-cash, equity-based compensation expense associated with option and RSU awards. (b) Represents transaction costs and expenses related to acquisition and integration efforts associated with recently announced or completed acquisitions. (c) Represents impa